Sector
DN and Holtzbrinck lead $8m round for Quandoo
DN Capital and Holtzbrinck Ventures have co-led an $8m series-B funding round for Quandoo, a Berlin-based restaurant reservation software provider.
DFJ Esprit et al. back Trustpilot
DFJ Esprit and its Menlo Park-based parent DFJ have led a $25m series-C round for consumer review site Trustpilot.
Sweet deal: Bencis's Continental Candy acquires K&H
Bencis Capital Partners-backed Continental Candy Industries (CCI) has acquired Kraepelien & Holm (K&H), a Dutch manufacturer of liquorice and wine gums.
Enterprise Investors and Intel sell Siveco back to management
Enterprise Investors and Intel Capital have sold Romanian software company Siveco Romania back to its management.
August supports SecureData bolt-on
August Equity has backed portfolio company SecureData Europe's acquisition of SensePost.
Pembroke et al. buy Boat International Media from August Equity
An investment consortium led by Pembroke Venture Capital Trust has acquired publishing and events group Boat International Media from August Equity.
$133m ATP deal marks Petroleum Equity's maiden investment
Petroleum Equity, a new private equity firm focused on oil and gas investments, has made its maiden investment with the acquisition of ATP Oil & Gas UK from US parent company ATP Oil & Gas Corporation.
XAnge and Isai back Evaneos
XAnge Private Equity and Isai have invested €4.4m in French travel firm Evaneos.
Octopus supports Michelson Diagnostics
Octopus Investments has led a £1.98m round for existing portfolio company Michelson Diagnostics, a UK-based medical devices company.
Nauta and Caixa inject further €3.5m into Groupalia
Nauta Capital and Caixa Capital Risc have injected a further €3.5m into daily deals site Groupalia to shore up the portfolio company.
CVC sells Matas stake for $216m
CVC Capital Partners has sold its entire holding in Danish beauty retailer Matas for $216m (DKK 1.18bn), equating to 19.4% of the total share capital.
Maven invests £3.5m in DMack
Maven Capital Partners has invested £3.5m in Carlisle-based tyre manufacturer DMack.
VC-backed Lombard to leave AIM for Nasdaq
Lombard Medical Technologies, a London-based medical devices company backed by Abingworth Management and MVM Life Science Partners, is planning to delist from the London Stock Exchange’s AIM and relist on the Nasdaq.
Caixa Capital Risc leads Lexdir investment
Caixa Capital Risc has led a €420,000 funding round for Lexdir, an online directory of legal professionals.
North West Fund backs FDM
The North West Fund for Venture Capital and the Lancashire Rosebud Fund have injected £860,000 into UK-based 3D printing company FDM Digital Solutions.
Deal in focus: VC-backed Okapi sold to US biopharma Aratana
The sale of venture-backed Belgian biopharmaceutical company Okapi Sciences to listed US biopharma Aratana Therapeutics highlights the benefits that come from maintaining relationships with former fellow investors.
Herkules acquires Didriksons
Herkules has agreed to acquire a majority stake in Didriksons, a Swedish functional clothing retailer.
VC-backed plista sold to GroupM
German advertising platform provider plista, backed by several venture capital firms, has been acquired by US-based GroupM, the parent company of WPP media agencies.
PE-backed Caffè Nero in £275m refinancing
Hutton Collins-backed Caffè Nero, a UK-based coffee shop chain, has completed a £275m refinancing comprising senior and mezzanine debt.
Erhvervsinvest backs Scanbur
Erhvervsinvest has invested in Danish life sciences company Scanbur.
Investcorp acquires Namet stake
Bahrain-based Investcorp has acquired a minority stake in Turkish meat company Namet Gida Saayi ve Ticareti.
Gimv and Alsace acquire Wolf in SBO
Gimv and Alsace Capital have acquired French designer and manufacturer of women’s underwear Wolf Group from Cathay Capital and EPF Partners.
Inventure Fund II holds first close on €50m
Inventure has held a first close for Inventure Fund II, an early-stage venture capital fund, on €50m.
Gilde acquires Viroclinics
Gilde Healthcare Services has acquired a majority stake in Viroclinics Biosciences, a Netherlands-based virology contact research organisation (CRO).